Home › Therapeutic areas › Metabolic › Pompe Disease

Pompe Disease (3 companies)

Companies with an active program in Pompe Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
DYN Dyne Therapeutics MetabolicNeurology Rare 1 NDA Submitted $3.00B 10
FBIO Fortress Biotech DermatologyHematology+4 Rare 1 Approved $61.4M 16
MAZE Maze Therapeutics MetabolicRenal Rare 1 Phase 2 $1.80B 4